Non-Hodgkin's lymphoma is a type of cancer that affects the lymphocytes--white blood cells that make up a component of the blood. Non-Hodigkin's lymphoma involves an enlargement of the lymph nodes throughout the body, which can lead to symptoms...
Biologic therapies, also called biologic agents, are cancer treatments that stimulate the body's immune system to recognize and destroy cancer cells, according to the University of Pittsburgh Cancer Institute. The therapy can consist of a single...
R-CHOP is a specific combination of chemotherapy drugs consisting of cyclophosphamide, doxorubicin hydrochloride, vincristine and prednisolone (CHOP), with the addition of rituximab (R). Rituximab is a monoclonal antibody that targets the protein...
Follicular lymphoma, also known as center cell non-Hodgkin's lymphoma, is a cancer that affects the b-lymphocytes. B-cell lymphocytes are the white blood cells that help defend the body against illness. Follicular describes the type of cell the...
Non-Hodgkin's lymphoma describes a condition of abnormal and uncontrolled growth of a specific type of white blood cell known as a lymphocyte. Lymphocytes, both B lymphocytes and T lymphocytes, function in the immune system and are concentrated in...
Rheumatoid arthritis is an autoimmune disorder associated with joint pain and numerous other manifestations that can affect areas of the body other than joints. The goal of therapy is to decrease inflammation and preserve the joints. According to...
B cell lymphoma is a subset of the group of diseases called non-Hodgkin lymphoma. According to the Leukemia & Lymphoma Society, these are a diverse group of diseases that involves the lymphatic system of the body. About 85 percent of patients...
Rituxan, the registered name for rituximab, is considered a frontline treatment for certain leukemias and B-cell lymphomas. Rituxan is also prescribed for patients with rheumatoid arthritis who do not respond to other therapies. Rituxan is given...
